PMID: 33801554 Endocrinology miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate-Activated Protein Kinase 1 in Male Mice
AbbVie announces positive topline results from a phase 1 multiple ascending dose study of ABBV-295, a long-acting amylin analog, in adults
Product 2: Highest grade available
Patients with cirrhosis frequently show increased sleep latency, diminished sleep maintenance and efficiency, alongside altered rapid-eye-movement (REM) sleep patterns
Consequently, agents that target the IL-1 pathway, such as anakinra (an IL-1 receptor antagonist) and canakinumab (a human anti-IL-1 monoclonal antibody), were investigated as potential treatment for SAH
This can lead to a more even complexion and reduction in dark spots or hyperpigmentation